BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1398556)

  • 1. Behavioral and cardiac responses after intracerebroventricular corticotropin-releasing hormone (CRH) administration: role of adrenal cortical hormones.
    Korte SM; Eisinga W; Timmerman W; Nyakas C; Bohus B
    Horm Behav; 1992 Sep; 26(3):375-84. PubMed ID: 1398556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central actions of corticotropin-releasing hormone (CRH) on behavioral, neuroendocrine, and cardiovascular regulation: brain corticoid receptor involvement.
    Korte SM; Bouws GA; Bohus B
    Horm Behav; 1993 Jun; 27(2):167-83. PubMed ID: 8394279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V; Soriano L; Dallman MF
    J Neuroendocrinol; 2001 May; 13(5):442-52. PubMed ID: 11328455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRH mRNA expression in the hypothalamic paraventricular nucleus is inhibited despite the activation of the hypothalamo-pituitary-adrenal axis during starvation.
    Nishiyama M; Makino S; Iwasaki Y; Tanaka Y; Nazarloo HP; Kaneda T; Asaba K; Hashimoto K
    Brain Res; 2008 Sep; 1228():107-12. PubMed ID: 18619422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
    Oitzl MS; van Haarst AD; Sutanto W; de Kloet ER
    Psychoneuroendocrinology; 1995; 20(6):655-75. PubMed ID: 8584606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.
    Linthorst AC; Flachskamm C; Hopkins SJ; Hoadley ME; Labeur MS; Holsboer F; Reul JM
    J Neurosci; 1997 Jun; 17(11):4448-60. PubMed ID: 9151762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats.
    Pich EM; Heinrichs SC; Rivier C; Miczek KA; Fisher DA; Koob GF
    Psychoneuroendocrinology; 1993; 18(7):495-507. PubMed ID: 8265737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone.
    Glavas MM; Ellis L; Yu WK; Weinberg J
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1598-610. PubMed ID: 17760789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
    Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
    J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses.
    Lu XY; Barsh GS; Akil H; Watson SJ
    J Neurosci; 2003 Aug; 23(21):7863-72. PubMed ID: 12944516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenalectomy reverses stress-induced suppression of luteinizing hormone secretion in long-term ovariectomized rats.
    McGivern RF; Redei E
    Physiol Behav; 1994 Jun; 55(6):1147-50. PubMed ID: 8047584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
    Schwartz MW; Strack AM; Dallman MF
    Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular porcine corticotropin-releasing hormone and cortisol effects on pig immune measures and behavior.
    Salak-Johnson JL; McGlone JJ; Whisnant CS; Norman RL; Kraeling RR
    Physiol Behav; 1997 Jan; 61(1):15-23. PubMed ID: 8976528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of hormones of hypothalamic-pituitary-adrenocortical system in analgesic effect of corticotropin-releasing hormone].
    Bogdanov AI; Iarushkina NI
    Ross Fiziol Zh Im I M Sechenova; 2006 Feb; 92(2):262-70. PubMed ID: 16739659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase activity is necessary for hypothalamo-pituitary-adrenal (HPA) responses to ether, and stress-induced facilitation of subsequent HPA responses to acute ether emerges as HPA responses are inhibited by increasing corticosterone (B).
    Murakami K; Akana SF; Dallman MF
    J Neuroendocrinol; 1997 Aug; 9(8):601-8. PubMed ID: 9283048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in the hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension.
    Hashimoto K; Makino S; Hirasawa R; Takao T; Sugawara M; Murakami K; Ono K; Ota Z
    Endocrinology; 1989 Sep; 125(3):1161-7. PubMed ID: 2547578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol.
    Jackson AL; Murphy LL
    Neuroendocrinology; 1997 Jun; 65(6):446-52. PubMed ID: 9208407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.
    Buckingham JC
    J Physiol; 1979 Jan; 286():331-42. PubMed ID: 220413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats.
    Grinevich V; Ma XM; Herman JP; Jezova D; Akmayev I; Aguilera G
    J Neuroendocrinol; 2001 Aug; 13(8):711-23. PubMed ID: 11489088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.